-
Persistence to Basal Insulin and Economic Outcomes Among Patients With Type 2 Diabetes: A Retrospective Analysis Using Electronic Health Records in England
Sep 9, 2025, 16:22 PM -
Occupational Disease Claims and Payments in Indonesia: Insights From Administrative Data 2018-2022
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
The Value of Persistence in Neovascular Age-Related Macular Degeneration
Sep 9, 2025, 16:22 PM -
Market Access AI Readiness: Maximizing Strategic Alignment Through Organizational Insights
Sep 9, 2025, 16:22 PM -
Are We SEEing It Yet? The Use of Structured Expert Elicitation Protocols for Decision Making
Sep 9, 2025, 16:22 PM -
Healthstate Utilities for Hormone Receptor-Positive (HR+) Human Epidermal Growth Factor-Receptor 2 Negative (HER2-) Breast Cancer
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Contemporary First-Line (1L) Treatments for Locally Advanced or Metastatic Urothelial Carcinoma La/mUC in France: A Sensitivity Analysis
Sep 9, 2025, 16:22 PM -
Spain Leveling Up: A Comparison of Spain’s New National Health Economic Evaluation Guideline With Those of England, France, Germany, Italy, Portugal, Sweden, Ireland, Canada, Australia, and Japan
Sep 9, 2025, 16:22 PM -
Optimizing HER2+ Breast Cancer Treatment Pathways in Italian Oncological Centers
Sep 9, 2025, 16:22 PM -
Evolution of Utilization and Costs of Long-Acting Injectable Antipsychotics (LAIs) in Outpatient Care at Lisbon Psychiatric Hospital (March-May 2022 vs. 2025)
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Different Payment Models on the Cost-Effectiveness and Budget Impact of Cell and Gene Therapies: Eladocagene Exuparvovec As a Case Study
Sep 9, 2025, 16:22 PM -
Societal Burden of Specific Learning Disorders With Focus on Secondary Mental Health Problems in Japan
Sep 9, 2025, 16:22 PM -
Patient Access Delays for Subsequent High-Value Indications of Multi-Indication Treatments: An Assessment of Health Technology Assessment Decision Making
Sep 9, 2025, 16:22 PM -
Costs and Health Outcomes of Meek Skin Micrografting vs. Mesh Skin Grafting in Adult Patients With Deep Partial Thickness and/or Full-Thickness Small (Burn) Wounds
Sep 9, 2025, 16:22 PM -
The Clinical Humanistic and Economic Burden of the Current Management of Patients With Recurrent Malignant Ascites in the UK and Europe
Sep 9, 2025, 16:22 PM -
Natural History of Creutzfeldt-Jakob Disease: A Comparison of Manual vs. Manual Plus AI-Assisted Approaches in Literature Review
Sep 9, 2025, 16:22 PM -
Prognostic Accuracy and Clinical Effectiveness of 68Ga-PSMA-11 PET/CT (ILLUCIX®) Imaging Followed by 177-Lu-PSMA-617 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Estimating the Public Health and Economic Impact of Recombinant Zoster Vaccine (RZV) Vaccination for Adults Aged 50 and Older in South Korea
Sep 9, 2025, 16:22 PM -
Measurement Properties of the EQ-5D in Hematological Cancers: A Systematic Review
Sep 9, 2025, 16:22 PM